$BLD

Donikowski Tina sold (to issuer) 4,123 shares of BLD

Donikowski Tina sold (to issuer) 4,123 shares of QXO Insulation, LLC (BLD) across 2 trades on 2026-07-01.

Original reporting
SEC EDGAR · Donikowski Tina
Published Jul 1, 2026, 9:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BLD
Neutral
low confidence
Mentioned
$BLD
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLDNeutralLow
01

Why it matters

The newest disclosed fact is the director’s sale of 4,123 shares to the issuer on 2026-07-01; no 10b5-1 plan is indicated and price/value are not disclosed.

02

Market read

This provides incremental insider-flow information for BLD but lacks disclosed economics (price/value), limiting tradable signal strength.

03

What to watch

Because the transaction is coded as sale to issuer and the price/value are not disclosed, traders should avoid over-interpreting directionality versus typical plan-driven liquidity events.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-01 (after-hours) for 2026-07-01 insider sale

Background

The filing is an SEC Form 4 insider transaction for QXO Insulation, LLC (BLD), reported by director Tina Donikowski.

Company-level read

Ticker impact

$BLDNeutralLow confidence
Context

SEC Form 4 shows director Donikowski Tina sold 4,123 shares of BLD to the issuer on 2026-07-01; price not disclosed.

Expected impact

Low near-term impact; any move would be more about broader tape than this Form 4.

Evidence & confidence

Form 4 insider transactions are typically informational but not usually market-moving unless unusually large, paired with other disclosures, or tied to a clear corporate action; here size is modest and sale price/value are not provided.

Market effects

None; this is company-specific insider transaction data with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

A sale to the issuer can be part of a structured program (e.g., tax/plan mechanics) and may not reflect bearish fundamentals; without disclosed price, signal is weaker.

Key entities

  • QXO Insulation, LLC

    Company subject of the Form 4 insider transaction (ticker BLD).

  • Tina Donikowski

    Director who sold 4,123 shares to the issuer on 2026-07-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QXOMedAI 9/10

QXO Inc. (QXO) Launches Cash Tender Offers for TopBuild (BLD) Senior Notes Amid Pending Acquisition

QXO Inc. said it launched cash tender offers and consent solicitations to buy TopBuild Corp.’s outstanding 4.125% notes due 2032 and 5.625% notes due 2034 as part of its pending acquisition of TopBuild. QXO offered $961.25 per $1,000 principal, plus $50 for early tenders ($1,011.25 total), and sought indenture amendments to remove a change-of-control offer and most restrictive covenants.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.